Strain Data Sheet

RBRC02346

Strain Information

Image
BRC No.RBRC02346
TypeTargeted MutationCartagena
SpeciesMus musculus
Strain nameFVB.129P2-Epb4.113<tm3Gvn>
Former Common nameDal1<flox3>, Protein4.1B<flox3>
H-2 Haplotype
ES Cell line
Background strainFVB/NJcl
Appearance
Strain development開発者／機関：INSERM U674開発年：2003年FVB/Nに10代backcrossした後、intercrossにて維持
Strain descriptionProtein4.1Bのexon3の両側にloxPが挿入されているマウス
Colony maintenance兄妹交配
References

Health Report

Examination Date / Room / Rack

Gene

Gene info
Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter
Epb4.1l3erythrocyte protein band 4.1-like 317Epb4.1l3<tm3Gvn>targeted mutation 3, Marco Giovannini4.1B, DAL1P, NBL3

Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter
loxPphage P1 loxP17loxP

Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter
loxPphage P1 loxP17loxP

Ordering Information

供与核酸Protein4.1B(Dal1)genomic DNA exon 3 前後にloxP site
Research applicationCre/loxP system
提供条件条件を付加する。
研究成果の公表にあたって謝辞の表明を必要とする。
RECIPIENT shall keep DEPOSITOR apprised of any results obtained from the BIOLOGICAL RESOURCE in the course of the research, as soon as they are available. Moreover, if the research results in a potential invention or a substance that may have potential commercial value (hereinafter referred as to the "Invention") RECIPIENT will promptly disclose this Invention to DEPOSITOR with samples thereof for DEPOSITOR's internal use.
RECIPIENT and DEPOSITOR will consult together and agree about the possibility of filing one or more patent application to Invention conceived by one or more employees of Recipients that directly arise out of the research. The Parties will negotiate in good faith the conditions of such patent application according to each party's inventiveness contribution in the Invention.
In case of such Invention, patentable or not, reduced in practice or developed in the course of the research that could not have been obtained, reduced to practice or developed but from using the Material and/or Confidential Information, RECIPIENT and DEPOSITOR shall confer with one another as regards licensing and commercialization of such Invention to negotiate in good faith the terms of an institutional agreement as regards said matters.
DepositorMarco Giovannini（INSERM）
Strain Status凍結胚のアイコン凍結胚
Strain Availability凍結胚より作出したマウスを2~4ヶ月以内に提供可能
凍結胚を1ヶ月以内に提供可能
Additional Info.Necessary documents for ordering:
  1. Order form (Japanese / English)
  2. Category I MTA: MTA for distribution with RIKEN BRC (Japanese / English)
  3. Acceptance of responsibility for living modified organism (Japanese / English)

Genotyping protocol -PCR-

BRC mice in Publications

No Data